Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective September 6, 2022, Brickell Biotech, Inc. (the "Company") amended its Amended and Restated Certificate of Incorporation (the "Certificate") and amended and restated its Amended and Restated Bylaws to change the Company's name to Fresh Tracks Therapeutics, Inc. (the "Name Change").

The Company's common stock began trading under the symbol "FRTX" on The Nasdaq Stock Market LLC on September 8, 2022.

A copy of the Certificate of Amendment to the Certificate to effect the Name Change (the "Charter Amendment"), as filed with the Secretary of State of the State of Delaware on September 6, 2022, is attached as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the Company's Certificate, as amended and restated to reflect the Charter Amendment, is attached as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated herein by reference. A copy of the Company's Amended and Restated Bylaws, as amended and restated to reflect the Name Change, is attached as Exhibit 3.3 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits



(d) Exhibits.

3.1              Certificate of Amendment to the Amended and Restated Certificate of
               Incorporation, dated September 6, 2022

3.2              Amended and Restated Certificate of Incorporation, as amended through September
               6, 2022

3.3              Amended and Restated Bylaws, as amended through September 6, 2022

104            Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses